ICU Medical, Inc. (ICUI)

ICU Medical Stock Forecast

Stock Price Forecast

According to 5 professional analysts, the 12-month price target for ICU Medical stock ranges from a low of $172 to a high of $200. The average analyst price target of $183.6 forecasts a 28.83% increase in the stock price over the next year.

Price Target: $183.60 (+28.83%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$172	$183.6	$180	$200
Change	+20.69%	+28.83%	+26.31%	+40.34%

* Price targets were last updated on Nov 7, 2025.

Analyst Ratings

The average analyst rating for ICU Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	2	2	2	2	2
Buy	2	3	3	3	3	3
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	6	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brett Fishbin Keybanc	Keybanc	Buy Maintains $173 → $175	Buy	Maintains	$173 → $175	+22.80%	Nov 7, 2025
Jason Bednar Piper Sandler	Piper Sandler	Buy Maintains $153 → $172	Buy	Maintains	$153 → $172	+20.69%	Nov 7, 2025
Brett Fishbin Keybanc	Keybanc	Buy Maintains $191 → $173	Buy	Maintains	$191 → $173	+21.39%	Oct 21, 2025
Jason Bednar Piper Sandler	Piper Sandler	Buy Maintains $145 → $153	Buy	Maintains	$145 → $153	+7.36%	Sep 10, 2025
Jason Bednar Piper Sandler	Piper Sandler	Buy Initiates $145	Buy	Initiates	$145	+1.75%	Aug 15, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.26B

Decreased by -5.21%

from 2.38B

Revenue Next Year

2.22B

Decreased by -1.55%

from 2.26B

EPS This Year

7.71

from -4.83

EPS Next Year

8.20

Increased by 6.42%

from 7.71

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.27B	1.32B	2.28B	2.26B	2.38B	2.26B	2.22B
Revenue Growth	0.38%	3.56%	73.21%	-0.92%	5.44%	-5.21%	-1.55%
EPS	4.02	4.74	-3.11	-1.23	-4.83	7.71	8.20
EPS Growth	-14.29%	17.91%	-	-	-	-	6.42%
Forward PE	-	-	-	-	-	18.49	17.37
No. Analysts	-	-	-	-	-	9	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	2.4B	2.4B
Avg	2.3B	2.2B
Low	2.2B	2.1B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-0.9%	7.0%
Avg	-5.2%	-1.6%
Low	-9.4%	-7.8%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	8.03	8.66
Avg	7.71	8.20
Low	7.33	7.77

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	12.4%
Avg	-	6.4%
Low	-	0.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.